The Cooley’s Anemia Foundation strives to ensure that every Thalassemia patient lives a longer, fuller life, and we will not rest until we find a cure for all.

70 Years of HopeEducationSupportResearch

70 Year Track Record of Accomplishments in the Fight Against Thalassemia

What is Thalassemia?

What is Thalassemia?

Hemoglobin is the oxygen-carrying component of the red blood cells. It consists of two different proteins, an alpha and a beta. If the body doesn’t produce enough of either of these two proteins, the red blood cells do not form properly and cannot carry sufficient oxygen. The result is anemia that begins in early childhood and lasts throughout life.

Beta Thalassemia occurs when hemoglobin lacks enough beta protein, primarily affecting individuals of Mediterranean, Middle Eastern, African, and Southeast Asian descent. It ranges from Thalassemia Minor, which typically causes no symptoms, to Thalassemia Major (Cooley's Anemia), the most severe form that requires regular blood transfusions and lifelong medical care to manage life-threatening anemia and iron overload.

Alpha Thalassemia occurs when the body doesn’t produce enough alpha protein in hemoglobin, commonly affecting people in Africa, Asia, and the Mediterranean. The condition ranges from the mild Silent Carrier State, with no symptoms, to the severe Alpha Thalassemia Major, which can cause life-threatening anemia and requires lifelong treatment.

Latest News & Events

Website Sponsors